0.805
2.72%
-0.0225
2.72%
-0.0225
(After Hours:
.81
+0.005
+0.62%
)
COMPANY PROFILE
NameNeurobo Pharmaceuticals
SectorHealthcare (1373)
IndustryBiotechnology (814)
Web
Phone857 702 9600
Employee12
SEC filings
Latest SEC Filings
Address200 Berkeley Street, 19th Floor, Boston, MA, United States (2116)Neurobo Pharmaceuticals (NRBO) Options Chain
Calls Options of NRBO for 2023-03-17 (Expired in 37 days)
| Strike | Price | Change | % Change | Volume |
|---|---|---|---|---|
0
|
0.00 | 0.00 | 0.00% | 0 |
|
0
|
0.00 | 0.00 | 0.00% | 0 |
|
0
|
0.00 | 0.00 | 0.00% | 0 |
|
2.50
|
0.21 | 0.00 | 0.00% | 0 |
|
5.00
|
0.00 | 0.00 | 0.00% | 0 |
|
7.50
|
0.00 | 0.00 | 0.00% | 0 |
Puts Options of NRBO for (Expired in 37 days)
| Strike | Price | Change | % Change | Volume |
|---|---|---|---|---|
|
0
|
0.00 | 0.00 | 0.00% | 0 |
|
0
|
0.00 | 0.00 | 0.00% | 0 |
|
0
|
0.00 | 0.00 | 0.00% | 0 |
|
2.50
|
0.00 | 0.00 | 0.00% | 0 |
|
5.00
|
0.00 | 0.00 | 0.00% | 0 |
|
7.50
|
0.00 | 0.00 | 0.00% | 0 |
About Neurobo Pharmaceuticals
NeuroBo Pharmaceuticals, Inc., a clinical-stage biotechnology company provides therapies for neurodegenerative and cardiometabolic diseases. Its therapeutics programs include NB-01 for the treatment of painful diabetic neuropathy; NB-02 to treat cognitive impairment and modify the progression of neurodegenerative diseases associated with the malfunction of protein; and Gemcabene, which is focused on developing and commercializing therapies for the treatment of dyslipidemia. NeuroBo Pharmaceuticals, Inc. was incorporated in 2017 and is headquartered in Boston, Massachusetts.
Real-Time Dow Stock List
Congresswoman Nancy Pelosi Stock Tracker
Top 100 popular stocks on Robinhood
Cap:
|
Volume (24h):